GRAS Notices
-
GRN No. 94
Docosahexaenoic acid-rich oil from tuna (DHA-rich tuna oil) and arachidonic acid-rich oil from Mortierella alpina (AA-rich fungal oil)
Intended Use: | Provide arachidonic acid (AA) at a mean level of 0.4 percent of total fatty acids and docosahexaenoic acid (DHA) at a mean level of 0.25 percent of total fatty acids in preterm infant formula used by hospitalized premature infants; AA at a mean level of 0.4 percent of total fatty acids and DHA at a mean level of 0.15 percent of total fatty acids in preterm infant formula used by post-discharge premature infants; and AA at a mean level of 0.4 percent of total fatty acids and DHA at a mean level of 0.15 percent of total fatty acids in term infant formula |
---|---|
Basis: | Scientific procedures |
Notifier: | Ross Products Division, Abbott Laboratories |
Notifier Address: | 625 Cleveland Avenue, Columbus, OH 43215-1724 |
Date of filing: | Jan 2, 2002 |
GRAS Notice (releasable information): | GRN 94 part 1 (in PDF) (13.0 MB) |
Part 2: | GRN 94 part 2 (in PDF) (16.1 MB) |
Date of closure: | Apr 18, 2006 |
FDA's Letter: | FDA has no questions |
-